 |
uridine triacetate |
|---|---|
| Trade Name | |
| Orphan Indication | An antidote in the treatment of 5-fluorouracil or capecitabine poisoning |
| USA Market Approval | USA |
| USA Designation Date | 2009-05-01 00:00:00 |
| Sponsor | Wellstat Therapeutics Corp.;14200 Shady Grove Road, Suite 600;Rockville, Maryland, 20850 |
